Trial
NCT06365437
A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
ITB-Med LLC
Collaborators
—
Condition
Kidney Transplantation
Intervention
TCD601
Why stopped
After enrolment was complete, and sufficient data was collected to fully characterize the highest dose cohort, study follow up was terminated by the sponsor for non-safety related reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-12